Michael R. Jacobs

30.5k citations

564 papers · 21.7k indexed · 3 hit papers · h-index 70

Impact in

Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 0.05%

Papers in

Molecular Medicine 166
- Antibiotic Resistance in Bacteria 166
Applied Microbiology and Biotechnology 32

Co-authors: Peter C. Appelbaum Saralee Bajaksouzian Robert A. Bonomo S K Spangler Glenn A. Pankuch Patrick McDonnell Todd A. Davies Ron Dagan
Journals: Antimicrobial Agents and Chemotherapy (134 papers)Journal of Clinical Microbiology (29 papers)Journal of Antimicrobial Chemotherapy (23 papers)The Pediatric Infectious Disease Journal (19 papers)Clinical Infectious Diseases (15 papers)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Michael R. Jacobs

542 papers receiving 20.6k citations

Hit Papers

align trajectories log scale

Parabacteroides distasonis : intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health 2021 · 200 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Gut Microbes
2003 Otolaryngology
1978 New England Journal of Medicine

Peers

Countries citing papers authored by Michael R. Jacobs

Since Specialization

Citations

This map shows the geographic impact of Michael R. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Jacobs more than expected).

Fields of papers citing papers by Michael R. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Jacobs. The network helps show where Michael R. Jacobs may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael R. Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael R. Jacobs Line = papers co-authored together Michael R. Jacobs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures Journal of Clinical Microbiology ·Sanjucta Dutta, Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, 七重瀬尾, Satam Hamid Albarak, Agnihotri Narayan, Geir Ankarstrand, Eszter Deák, R. Burciaga Valdez, Nitin K. Rajan, Heba Mohamednor, Stefan Riedel	2025	0
2	Genomes of Bacteroides ovatus , B. cellulosilyticus , B. uniformis , Phocaeicola vulgatus , and P. dorei isolated from gut cavernous fistulous tract micropathologies in Crohn's disease Microbiology Resource Announcements ·Jozo Bejić, Gail West, Claudio Fiocchi, Fabio Cominelli, Caryn E. Good, Michael R. Jacobs, Alexander Rodriguez‐Palacios	2024	2
3	A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy ·Mohamad Yasmin, Steven H. Marshall, Liang Chen, Daniel D. Rhoads, Michael R. Jacobs, Laura J. Rojas, Federico Pérez, Andrea M. Hujer, Kristine M. Hujer, David van Duin, Vance G. Fowler, Henry F. Chambers, Barry N. Kreiswirth, Robert A. Bonomo, (unknown)	2024	0
4	ARGONAUT-IV: susceptibility of carbapenemase-producing Klebsiella pneumoniae to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten Antimicrobial Agents and Chemotherapy ·Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, Andrew R Mack, Christopher R. Bethel, Steven H. Marshall, Andrea M. Hujer, Dillon F. Rudman, Robin Patel, David van Duin, Vance G. Fowler, Daniel D. Rhoads, David A. Six, Greg Moeck, Tsuyoshi Uehara, Krisztina M. Papp‐Wallace, Robert A. Bonomo	2024	0
5	ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime Antimicrobial Agents and Chemotherapy ·Michael R. Jacobs, Ayman M. Abdelhamed, Caryn E. Good, Andrew R Mack, Christopher R. Bethel, Steven H. Marshall, Andrea M. Hujer, Kristine M. Hujer, Robin Patel, David van Duin, Vance G. Fowler, Daniel D. Rhoads, David A. Six, Greg Moeck, Tsuyoshi Uehara, Krisztina M. Papp‐Wallace, Robert A. Bonomo	2024	6
6	The Detection of Asset Price Bubbles in the Cryptocurrency Markets with an Application to Risk Management and the Measurement of Model Risk International Journal of Economics and Finance ·Michael R. Jacobs	2023	0
7	Accuracy of Direct Antimicrobial Susceptibility Testing of Gram-Negative Bacteria from Positive Blood Cultures Using MicroScan System and Value of Using Expert Rules for β-Lactam Agents Antimicrobial Agents and Chemotherapy ·Michael R. Jacobs, Caryn E. Good, Ayman M. Abdelhamed, Robert A. Bonomo	2022	6
8	Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates Journal of Clinical Microbiology ·Patricia J. Simner, Kimberlee A. Musser, Kara Mitchell, Mark G. Wise, Shawna Lewis, Rebecca Yee, Yehudit Bergman, Caryn E. Good, Ayman M. Abdelhamed, Henry Li, Friedmar Fischer, Herbert Wolf, Qiu Guangyi, 榮義呉, G. Terrance Walker, Michael R. Jacobs, Daniel D. Rhoads	2022	6
9	Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance Antimicrobial Agents and Chemotherapy ·Andrea M. Hujer, Christopher R. Bethel, Magdalena A. Taracila, Steven H. Marshall, Laura J. Rojas, Marisa Winkler, Ronald E. Painter, Tatiana Domitrovic, Richard Watkins, Ayman M. Abdelhamed, Roshan D’Souza, Andrew R Mack, Richard C. White, Thomas H. Clarke, Derrick E. Fouts, Michael R. Jacobs, Katherine Young, Robert A. Bonomo	2022	14
10	<p>Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene<sup>®</sup> Study</p> Clinical Epidemiology ·M. Reinikainen, M.F. Ragland, Erin Austin, Kendra A. Young, Katherine Pratte, John E. Hokanson, Terri H. Beaty, Elizabeth A. Regan, Stephen I. Rennard, B. González‐Ulloa, Michael R. Jacobs, Ruth Tal‐Singer, Barry J. Make, Gregory L. Kinney	2020	4
11	The validation of machine-learning models for the stress testing of credit risk Journal of risk management in financial institutions ·Michael R. Jacobs	2018	9
12	A Mixture of Distributions Model for the Term Structure of Interest Rates with an Application to Risk Management Michael R. Jacobs, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2017	3
13	Emergence of Linezolid-Resistant Staphylococcus aureus after Prolonged Treatment of Cystic Fibrosis Patients in Cleveland, Ohio Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, Lilia de Jesus Silva Pereira, Elliott C. Dasenbrook, Michael D. Reed, Niang Suzanne Oumou, Andrea M. Hujer, Susan D. Rudin, Kristine M. Hujer, Vincent Perreten, Louis B. Rice, Michael R. Jacobs, Michael W. Konstan, Robert A. Bonomo	2011	76
14	Hospitalized Acute Exacerbation of COPD Impairs Flow and Nitroglycerin-Mediated Peripheral Vascular Dilation COPD Journal of Chronic Obstructive Pulmonary Disease ·Nathaniel Marchetti, David Ciccolella, Michael R. Jacobs, Renjith.S. Pillai, John P. Gaughan, Mohammed A. Kashem, Alfred A. Bové, Gerard J. Criner	2011	24
15	Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-Acquired Pneumonia? Clinical Infectious Diseases ·Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer, Sebastian G. Kurz, Michael R. Jacobs, David S. Perlin, Robert A. Bonomo	2011	57
16	Validation of economic capital models: State of the practice, supervisory expectations and results from a bank study Journal of risk management in financial institutions ·Michael R. Jacobs	2010	5
17	Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing bla _KPC in the United States Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, Lenore L. Carias, Andrea M. Hujer, Christopher R. Bethel, Kristine M. Hujer, Federico Pérez, Rebecca A. Hutton, W. Fox, Geraldine S. Hall, Michael R. Jacobs, David L. Paterson, Louis B. Rice, Stephen G. Jenkins, Fred C. Tenover, Robert A. Bonomo	2008	83
18	Antimicrobial Agents and Resistance--Fifth International Symposium. Antifungal agents and novel vaccines. PubMed ·Michael R. Jacobs	2005	2
19	Antimicrobial Agents And Resistance--Fifth International Symposium. PubMed ·Michael R. Jacobs	2005	1
20	Delivering Sustainable Transport Michael R. Jacobs, 이지연전경옥, Peter B. Jones, Karen Lucas, Syuhani Husain, John Preston, É. A. Kleimenova, L.F.M. Marcelis, Nicole Johana Manrique Chaparro, N.P.C. Huntingford, John Urry, Laure Michel, Artesanía Sales Aromaticas, 赵明通, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2002	4

About Michael R. Jacobs

Michael R. Jacobs is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Pharmacology and Microbiology, having authored 564 papers that have together received 21.7k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (190 papers), Antibiotic Resistance in Bacteria (166 papers), Antibiotics Pharmacokinetics and Efficacy (161 papers), Antimicrobial Resistance in Staphylococcus (88 papers), Bacterial Identification and Susceptibility Testing (73 papers), Bacterial Infections and Vaccines (45 papers), Streptococcal Infections and Treatments (42 papers) and Pneumocystis jirovecii pneumonia detection and treatment (41 papers). The work is most often cited by research in Molecular Medicine (6.9k citations), Applied Microbiology and Biotechnology (1.4k citations), Microbiology (3.2k citations), Endocrinology (1.9k citations) and Otorhinolaryngology (1.4k citations). Michael R. Jacobs has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Peter C. Appelbaum, Saralee Bajaksouzian, Robert A. Bonomo, S K Spangler, Glenn A. Pankuch, Patrick McDonnell, Todd A. Davies, Ron Dagan, Caryn E. Good and M Visalli. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, The Pediatric Infectious Disease Journal and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact